All articles
Tirzepatide Dosage in Units: A Full Chart From 2.5 to 15 mg
Reading time:
11 mins
Weight loss

The full chart puts every labeled dose in units at three example strengths
This is a tirzepatide dosage chart in units for the whole labeled schedule, converted with the formula above. The three concentrations, 5, 10 and 20 mg/mL, are examples picked to show the math, the same ones used in the single-dose 2.5 mg guide. They are not the strength of any specific product, including any vial you receive.
Concentration differs between pharmacies and vials. Follow your provider’s instructions and your vial label, and ask your pharmacist or provider if your units don’t match.
Dose | EXAMPLE 5 mg/mL | EXAMPLE 10 mg/mL | EXAMPLE 20 mg/mL |
2.5 mg | 0.5 mL = 50 units | 0.25 mL = 25 units | 0.125 mL = 12.5 units |
5 mg | 1 mL = 100 units | 0.5 mL = 50 units | 0.25 mL = 25 units |
7.5 mg | 1.5 mL = 150 units* | 0.75 mL = 75 units | 0.375 mL = 37.5 units |
10 mg | 2 mL = 200 units* | 1 mL = 100 units | 0.5 mL = 50 units |
12.5 mg | 2.5 mL = 250 units* | 1.25 mL = 125 units* | 0.625 mL = 62.5 units |
15 mg | 3 mL = 300 units* | 1.5 mL = 150 units* | 0.75 mL = 75 units |
*More than a 1 mL (100-unit) syringe holds.
Read across one row and a pattern jumps out. Double the concentration, and the units for the same dose drop by half. Read down a column and the units climb in even steps, because each step on the label adds the same 2.5 mg.
So a chart passed along by a friend, a forum or another pharmacy can be off by a factor of two or four for your vial. Your label decides.
A 1 mL syringe tops out at 100 units, so some chart cells won’t fit
U-100 insulin syringes come in 0.3 mL, 0.5 mL and 1 mL sizes, which hold up to 30, 50 and 100 units (4). On a standard 1 mL insulin syringe, every small notch is 1 unit (3). Any chart cell above 100 units can’t be drawn in one standard 1 mL syringe.
Syringe size | Holds up to | Example chart values that fit |
0.3 mL | 30 units | 12.5 and 25 units |
0.5 mL | 50 units | 37.5 and 50 units, plus anything smaller |
1 mL | 100 units | 62.5, 75 and 100 units, plus anything smaller |
Two more catches. Half-unit values like 12.5 or 37.5 fall between the whole-unit marks on a syringe marked in 1-unit steps, so ask your pharmacist exactly how to measure them. And if your number is bigger than your syringe, that’s a question for your pharmacy or provider. Don’t solve it by guessing.
Your vial label and your provider’s written instructions are the numbers that count.
Six checks make any units chart safe to read
A chart is only useful if it matches your supplies. Before you use any units chart, including the one above, confirm these six things in order. If any one of them doesn’t line up, call your pharmacy or provider before you inject.
Find the concentration on your vial label, written in mg/mL. If the label shows only total milligrams and total milliliters, divide them, so 20 mg in 2 mL would be 10 mg/mL.
Find that same concentration in the chart’s column header. No match means the chart isn’t for your vial.
Confirm your syringe is marked U-100 (3).
Find the dose your provider wrote for you in the chart’s rows, not a step you expect to reach later.
Read the cell where your row and column meet, and note both the mL and the units.
Compare that number with your provider’s written instructions. If they differ, ask before you inject.
You can also check how and where to inject once the numbers line up.
Most unit mismatches trace back to five mistakes
When the FDA reviewed dosing errors with compounded semaglutide injections, it found patients drawing more than intended from multiple-dose vials, sometimes five to 20 times the intended dose (5). It also found providers miscalculating conversions from milligrams to units or milliliters (5). The same traps apply to any medication drawn by units.
Using a chart built for another concentration. A chart that’s right for someone else’s vial gives you a wrong number for yours.
Reading milliliters as units. 0.25 mL is 25 units. Mixing the two shifts a dose by a factor of 100.
Carrying old units to a new vial. A refill at a different concentration changes the units for the same mg dose. Check every new label.
Using the wrong syringe. The FDA has reported patients getting syringes far larger than the prescribed volume, including cases where people directed to take 5 units took 50 units instead (5).
Dropping a decimal. 12.5 units is not 125 units.
Reported overdose effects in those FDA reports included nausea, vomiting and abdominal pain, and some people sought medical attention or needed hospital care (5). If you think you injected too much, call Poison Help at 1-800-222-1222. Call 911 if someone collapses, has a seizure, has trouble breathing or can’t be woken up (7).
The same chart works backward, from units to milligrams
If your instructions list units and you want to know the milligram dose, reverse the formula: mg = (units ÷ 100) × concentration in mg/mL. Units divided by 100 gives milliliters, and milliliters times concentration gives milligrams (3). The table uses the same example strengths.
Units drawn | Volume | EXAMPLE 5 mg/mL | EXAMPLE 10 mg/mL | EXAMPLE 20 mg/mL |
15 units | 0.15 mL | 0.75 mg | 1.5 mg | 3 mg |
35 units | 0.35 mL | 1.75 mg | 3.5 mg | 7 mg |
60 units | 0.6 mL | 3 mg | 6 mg | 12 mg |
75 units | 0.75 mL | 3.75 mg | 7.5 mg | 15 mg |
Look at 60 units. It could mean 3 mg or 12 mg. The unit count tells you nothing until you know the vial. For 20, 25, 30, 40 and 50 units, see the units to mg guide.
These are example concentrations, not your dose. Follow your provider’s instructions and your vial label.
Branded pens and vials are measured in milliliters, not units
Zepbound and Mounjaro single-dose pens and vials each hold one dose of 2.5, 5, 7.5, 10, 12.5 or 15 mg in 0.5 mL (1,2). The four-dose KwikPen and multi-dose vial deliver each dose in 0.6 mL (1,2). Neither label doses in insulin units.
The Zepbound multi-dose vial instructions call for a syringe that can measure a 0.5 mL or 0.6 mL dose, such as a 1 mL syringe (1). You draw to the 0.6 mL line (1). Here the logic flips. With branded products, the volume stays the same at every step and the concentration changes. With a compounded vial at one concentration, the concentration stays put and the volume grows as your dose rises.
Product | Regulatory status | How each dose is measured | Volume as the dose rises |
Zepbound or Mounjaro single-dose pen or vial | FDA-approved | One fixed dose in 0.5 mL | Stays at 0.5 mL |
Zepbound or Mounjaro KwikPen or multi-dose vial | FDA-approved | Four doses, each 0.6 mL | Stays at 0.6 mL |
Compounded tirzepatide vial | Not FDA-approved | Drawn by syringe per your provider and vial label | Depends on the vial’s concentration |
For pen technique, see how to inject Mounjaro.
Compounded tirzepatide has no labeled dosing chart
Compounded tirzepatide is not Zepbound or Mounjaro. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Without an FDA-approved label, there’s no official compounded dosing chart. Your provider sets your mg dose, and your pharmacy label sets the concentration.
The FDA notes that product concentrations may vary depending on the compounder (5). It has also warned about fraudulent products sold as compounded tirzepatide, and it reported receiving more than 730 adverse event reports associated with compounded tirzepatide as of May 31, 2026 (6). For more on the rules, see FDA guidance on compounding.
The 2.5 to 15 mg schedule above comes from the Zepbound and Mounjaro labels. It’s shown so you can follow the math, not as a schedule for any compounded product.
If you use compounded tirzepatide through Mochi Health, an affiliated Mochi Medical provider decides your dose, and your vial label and written instructions tell you how many units to draw. Ask whenever the numbers don’t add up. You can check your eligibility to talk with a licensed provider.
Tirzepatide carries a boxed warning for thyroid C-cell tumors
Zepbound and Mounjaro carry a boxed warning for risk of thyroid C-cell tumors. Tirzepatide caused these tumors in rats, and whether it causes them in humans is unknown (1,2). You should not use tirzepatide if you or a family member has had medullary thyroid carcinoma, or if you have multiple endocrine neoplasia syndrome type 2 (1,2).
It’s also off-limits if you’ve had a serious allergic reaction to tirzepatide or any ingredient in the product (1). A provider will discuss the boxed warning with you, including the symptoms of thyroid tumors to watch for.
Common side effects are a separate topic. For the full picture, see tirzepatide side effects.
The bottom line
Tirzepatide is dosed in milligrams. Units are just how a U-100 syringe measures the liquid, so the right number of units always depends on your vial’s concentration. The labeled schedule runs from 2.5 mg to 15 mg in 2.5 mg steps (1,2), and the chart above shows how that schedule converts at example strengths.
Use it to understand the math. Then follow your provider’s instructions and your vial label, and ask your pharmacist or provider before you inject if anything doesn’t match. When you’re ready, check your eligibility to talk with a licensed provider on the Mochi Health platform.
Frequently asked questions
How many units is 5 mg of tirzepatide?
It depends on your vial. At example concentrations on a U-100 syringe, 5 mg is 100 units at 5 mg/mL, 50 units at 10 mg/mL and 25 units at 20 mg/mL (3). Check the concentration on your own vial label.
How many units is 15 mg of tirzepatide?
At an example 20 mg/mL vial, 15 mg is 0.75 mL, or 75 units. At 10 mg/mL it would be 150 units, more than a 1 mL syringe holds (4). 15 mg is the maximum weekly dose on the Zepbound and Mounjaro labels (1,2).
Why doesn’t a tirzepatide dosing chart in units match your prescription?
Usually the chart was built for a different concentration than your vial, or it lists mL where your instructions list units. Call your pharmacy or provider and read them the concentration on your label.
What happens if you miss a weekly dose?
The Zepbound label says to take a missed dose within 4 days (96 hours) of when it was due. If more than 4 days have passed, skip it and take your next dose on your usual day (1,7). If your provider gave you different instructions, follow those.
References
Eli Lilly and Company. Zepbound (tirzepatide) injection, prescribing information. DailyMed, National Library of Medicine. Revised August 2026. DailyMed
Eli Lilly and Company. Mounjaro (tirzepatide) injection, prescribing information. DailyMed, National Library of Medicine. Revised August 2026.
National Library of Medicine. Giving an insulin injection. MedlinePlus Medical Encyclopedia. Accessed November 19, 2026. MedlinePlus
McKee AM, Yancey AM, Zhang RM, McGill JB. The nuances surrounding insulin prescribing. Clinical Diabetes. 2023;41(3):411-419. PMCID: PMC10338272.
US Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024. FDA
US Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. Content current as of October 1, 2026.
National Library of Medicine. Tirzepatide injection. MedlinePlus Drug Information. Accessed November 19, 2026.
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. Compounded tirzepatide, Zepbound and Mounjaro require a written prescription from a licensed provider. Speak with a provider to determine if these medications are appropriate for you. Zepbound is FDA-approved, with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight and at least one weight-related condition, and to treat moderate to severe obstructive sleep apnea in adults with obesity. Mounjaro is FDA-approved, with diet and exercise, to improve blood sugar control in adults and children 10 years and older with type 2 diabetes. Zepbound and Mounjaro carry a boxed warning for risk of thyroid C-cell tumors that a provider will discuss with you. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results are not guaranteed and may vary from person to person. All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.
Share this post
Weight loss
More articles





